• Android Developer

    Job Location UK-Nottingham
    Regular Full-Time
  • Overview

    Android Developer


    The role will provide software design, development and application support to drive forward our native application solutions.




    Android Developer


    The role will provide software design, development and application support to drive forward our native application solutions.


    Essential Duties And Responsibilities


    Working within a cross functional Scrum team


    Analyse, design and develop native mobile app solutions


    Identify and resolve app issues


    Assess the health and performance of apps


    Provide appropriate research support to business groups within the organization


    Recommend solutions for new ideas


    Identify and recommend solutions for problems


    Qualifications / Experience


    Experience of analysis and documentation techniques including user stories, use cases, design specifications and the ownership of those solutions through to delivery.


    Excellent knowledge of object oriented development techniques with particular emphasis on Kotlin, Java, and the Android SDK.


    Experience of libraries such as Realm, Retrofit, and RxJava

    Development experience with securing applications for Android phones and tablets


    Experience of the full SDLC, ideally with an agile approach


    Experience with RESTful APIs and JSON


    Experience of continuous integration / continuous delivery


    Ideally an understanding of large corporate/matrix organization processes and procedures



    What we Offer


    Competitive Salary plus Annual bonus target (Based on EBITDA and personal performance)


    Excellent On-Boarding plan


    Tuition Reimbursement up to $10,000


    Global Hackathon Event 


    Flexible working


    Group Pension Plan 


    Death In Service (x4 salary)


    Health Insurance (Vitality)


    Private Medical for self (you can pay to add family member)


    33 days holiday 


    Free and ample onsite parking


    We offer a global exchange scheme meaning you can apply to work in any of our global locations for 4 weeks and an 8 hour exchange scheme were you can work in another department for 8 hours - great opportunities to learn more of what others do and different cultures.


    We run Yoga and boot camp classes and have both social and wellness committees, so we enjoy many celebrations and plenty of free fruit.


    Additionally we have completed the refurbishment of our Nottingham offices providing a larger breakout area, more showers and larger office spaces - come take a look !


    Who we are and what we do


    ERT’s solutions are designed to enhance trial oversight optimisation; increasing patient engagement and allowing maximum transparency in the efficacy of new clinical treatments.


    Since 2014, more than half of all FDA drug approvals (60% in 2017) have come from ERT supported studies and during this time, 10,000+ studies, incorporating over three million patients, have been undertaken by Pharma, CRO and Biotechnology companies utilising ERT solutions. 


    Since this time, the newly christened Digital Patient Group of ERT (the former Exco InTouch) has led innovation into new expansion markets including Real World Data and Patient Support within the Phase IV market.


    Utilising proprietary system solutions such as GATHER, a fully scalable, affordable data capture and analytic program suite, along with custom solutions and strategic partnerships to implement solutions in these markets have been identified as areas of high growth and are being specifically targeted by ERT as their next area of high profitability.


    ERT is positioning itself within this area of massive potential in response to the significant shift in focus toward holistic patient management and improved real-world outcomes. The Digital Patient Group at ERT provides these digital services and patient engagement solutions to support the patient journey from clinical to real world by helping patients remain actively involved with the program and adherent to treatment regimens.




    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed